Evidence map›Paper›PMID 38670624›Full record

ArticleBMJ open2024

Evaluating low and high vitamin D levels in Ecuadorian cities from 2018 to 2022: interrupted time series and a cross-sectional study.

Camilo Zurita-Salinas, Betzabé Tello, Iván Dueñas-Espín, Jeannete Zurita, William Acosta, Cristina Aguilera León, Andrés Andrade-Muñoz, José Pareja-Maldonado

Abstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Camilo Zurita-SalinasBiomedical Research Unit, Zurita & Zurita Laboratories, Quito, Ecuador.
Betzabé TelloFacultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, Ecuador bmtello@puce.edu.ec.ORCID 0000-0001-5890-6436
Iván Dueñas-EspínInstituto de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.ORCID 0000-0002-6639-727X
Jeannete ZuritaBiomedical Research Unit, Zurita & Zurita Laboratories, Quito, Ecuador.
William AcostaFacultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
Cristina Aguilera LeónBiomedical Research Unit, Zurita & Zurita Laboratories, Quito, Ecuador.
Andrés Andrade-MuñozFacultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
José Pareja-MaldonadoFacultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify differences in the mean vitamin D concentrations in samples obtained from a private laboratory in Quito and to explore their relationship with the pre-pandemic and pandemic periods spanning from 2018 to 2022.

designA combination of an interrupted time series design and a retrospective cross-sectional approach. SETTING AND

participantsThe study involved 9285 participants who had their 25-hydroxyvitamin D (25(OH)D) levels tested at a well-known private laboratory in Quito, Ecuador, from 2018 to 2022. PRIMARY AND SECONDARY OUTCOME MEASURES: The 25(OH)D levels were analysed and assessed for correlations with age, and the year the measurements were taken.

resultsThe mean 25(OH)D level was 27.53 ng/mL (± 14.11). Approximately 68.8% of participants had serum 25(OH)D levels of less than 30 ng/mL, and 0.6% showed potential harm from excess 25(OH)D, with levels over 100 ng/mL. The analysis indicated a significant monthly increase of 0.133 units in 25(OH)D levels (p=0.006). However, the period after March 2020, compared with before, saw a non-significant decrease of 1.605 units in mean 25(OH)D levels (p=0.477).

conclusionsThe study's findings indicate a significant prevalence of 25(OH)D deficiency, underscoring the necessity for preventative measures. However, the increasing trend in high 25(OH)D levels is concerning, emphasising the importance of prudent vitamin D supplement prescriptions and public education against self-medication. For efficient resource allocation and targeting of those with higher risks, it may be advantageous to concentrate vitamin D testing on specific population groups.

Indexed as

Interrupted Time Series AnalysisVitamin DVitamin D DeficiencyAdolescentAdultAgedChildChild, PreschoolCitiesCOVID-19Cross-Sectional StudiesEcuadorFemaleHumansInfantMale25-hydroxyvitamin DVitamin DALTITUDE MEDICINEPrimary Health CarePUBLIC HEALTHSafetyToxicity

Identifiers

PMID38670624
PMCPMC11057257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.